Latest News
Multi-strategy hedge fund Verition has bolstered its team by appointing Mark Almond as its new head of support. Almond joined Verition this week after a four-year stint at Schonfeld, another prominent hedge fund, according to a report by eFinancial Careers.
Marshall Wace, the $69bn London-based hedge fund firm founded by Paul Marshall and Ian Wace, has selected Bloomberg’s IBVAL Front Office to provide intraday pricing info to support idea generation and pre-trade analysis for the firm’s multi-asset strategy.
The manager of Katsu Fund, a hedge fund marketed as using artificial intelligence (AI) to guide its trading strategies, has been arrested and charged with securities fraud, wire fraud, and money laundering, according to a report by Investment Executive.
Hound Partners, a hedge fund launched with support from Julian Robertson’s Tiger Management, has filed a lawsuit to terminate a profit-sharing agreement dating back to 2004, according to a report by Bloomberg.
Bridgewater Associates, one of the world’s largest hedge funds, is teaming up with State Street Global Advisors (SSGA) to bring its investment strategies to retail investors, marking a significant shift in its approach to the market, according to a report by the Financial Times.
The rapid expansion of multi-strategy hedge funds is at an end, according to Ken Griffin, founder of Citadel, who, in an interview with Bloomberg News after speaking at the Oxford union this week, said: “That chapter has come and gone.”
Turkey’s lira weakened on Monday as state banks scaled back efforts to defend the currency, prompting hedge funds and other traders to unwind carry trades, according to a report by Bloomberg citing sources familiar with the matter.
Syz Capital, the $1.8bn alternatives investment arm of the family owned Syz Group, has appointed Ursula Nitschke as its new Head of Business Development and Investor Relations, with responsibility for capital raising and communications.
Polymer Capital Management has brought on Chiga Murayama, a senior portfolio manager previously with BlueCrest Capital Management, following his departure after market turbulence in August caused significant losses among yen rates traders, according to a report by Bloomberg.
CVS Health is adding four new members to its board of directors, including Larry Robbins, CEO of Glenview Capital Management—the hedge fund firm which has been pushing for changes at the healthcare giant after acquiring a significant stake in the business.
Special Reports
FeatureD
- Insight
